Li, J., Jubb, A., & Harris, A. (2010). Targeting DLL4 in tumors shows preclinical activity but potentially significant toxicity.
Chicago-čujuhus (17. p.)Li, J., A. Jubb, juo A. Harris. Targeting DLL4 in Tumors Shows Preclinical Activity but Potentially Significant Toxicity. 2010.
MLA-čujuhus (9. p.)Li, J., et al. Targeting DLL4 in Tumors Shows Preclinical Activity but Potentially Significant Toxicity. 2010.
Muitte dárkkistit čujuhemiid riektatvuođa, ovdal go geavahat daid iežat deavsttas.